SREBF1 and atherosclerosis: Taken together with strong staining of SREBP-1 in human atherosclerosis (Fig. 1), these results suggest that the proteolytic activation of SREBP-1 and its associated lipogenic process may contribute to lipid accumulation and deposition in atherosclerotic aorta.